NEW YORK (GenomeWeb News) — Helicos for the second time in a week ratcheted down its share price for its planned initial public offering, cutting the price of its shares to $9 — a 40-percent drop from the high end of its original plan — according to a filing with the US Securities and Exchange Commission today.
 
Earlier this week, the company cut the price of the 5.4 million shares it is offering to between $10 and $11 per share from an original projection of between $13 and $15 per share, according to an earlier SEC filing.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.